nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—PTGS1—Etoposide—muscle cancer	0.2	0.368	CbGbCtD
Sulfamethoxazole—CYP2C8—Etoposide—muscle cancer	0.115	0.212	CbGbCtD
Sulfamethoxazole—ALB—Methotrexate—muscle cancer	0.0985	0.181	CbGbCtD
Sulfamethoxazole—CYP3A4—Vincristine—muscle cancer	0.051	0.0939	CbGbCtD
Sulfamethoxazole—CYP3A4—Etoposide—muscle cancer	0.0467	0.0861	CbGbCtD
Sulfamethoxazole—CYP3A4—Doxorubicin—muscle cancer	0.0319	0.0587	CbGbCtD
Sulfamethoxazole—NAT2—renal system—muscle cancer	0.00499	0.176	CbGeAlD
Sulfamethoxazole—NAT1—tendon—muscle cancer	0.00355	0.125	CbGeAlD
Sulfamethoxazole—NAT1—bone marrow—muscle cancer	0.00344	0.121	CbGeAlD
Sulfamethoxazole—NAT1—vagina—muscle cancer	0.00329	0.116	CbGeAlD
Sulfamethoxazole—NAT1—testis—muscle cancer	0.00294	0.103	CbGeAlD
Sulfamethoxazole—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00282	0.00659	CcSEcCtD
Sulfamethoxazole—Stomatitis—Dactinomycin—muscle cancer	0.00278	0.00648	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Vincristine—muscle cancer	0.00271	0.00632	CcSEcCtD
Sulfamethoxazole—UGT1A9—renal system—muscle cancer	0.0027	0.0948	CbGeAlD
Sulfamethoxazole—Neutropenia—Vincristine—muscle cancer	0.00267	0.00623	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Dactinomycin—muscle cancer	0.00266	0.0062	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Vincristine—muscle cancer	0.0026	0.00608	CcSEcCtD
Sulfamethoxazole—Neuritis—Doxorubicin—muscle cancer	0.00256	0.00597	CcSEcCtD
Sulfamethoxazole—Pneumonia—Vincristine—muscle cancer	0.00256	0.00597	CcSEcCtD
Sulfamethoxazole—Hepatitis—Dactinomycin—muscle cancer	0.00256	0.00597	CcSEcCtD
Sulfamethoxazole—Depression—Vincristine—muscle cancer	0.00254	0.00592	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Vincristine—muscle cancer	0.00249	0.00582	CcSEcCtD
Sulfamethoxazole—Stomatitis—Vincristine—muscle cancer	0.00248	0.00579	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Dactinomycin—muscle cancer	0.00242	0.00564	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00241	0.00562	CcSEcCtD
Sulfamethoxazole—Glossitis—Methotrexate—muscle cancer	0.00239	0.00559	CcSEcCtD
Sulfamethoxazole—Oliguria—Methotrexate—muscle cancer	0.00239	0.00559	CcSEcCtD
Sulfamethoxazole—Hepatic enzyme increased—Methotrexate—muscle cancer	0.00233	0.00544	CcSEcCtD
Sulfamethoxazole—Chills—Dactinomycin—muscle cancer	0.00229	0.00535	CcSEcCtD
Sulfamethoxazole—Blood disorder—Doxorubicin—muscle cancer	0.00229	0.00534	CcSEcCtD
Sulfamethoxazole—Hallucination—Vincristine—muscle cancer	0.00227	0.0053	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Vincristine—muscle cancer	0.00226	0.00526	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Vincristine—muscle cancer	0.00224	0.00524	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Vincristine—muscle cancer	0.00224	0.00522	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Etoposide—muscle cancer	0.0022	0.00512	CcSEcCtD
Sulfamethoxazole—Jaundice cholestatic—Doxorubicin—muscle cancer	0.00217	0.00508	CcSEcCtD
Sulfamethoxazole—Neutropenia—Etoposide—muscle cancer	0.00216	0.00504	CcSEcCtD
Sulfamethoxazole—Oliguria—Doxorubicin—muscle cancer	0.00207	0.00484	CcSEcCtD
Sulfamethoxazole—Glossitis—Doxorubicin—muscle cancer	0.00207	0.00484	CcSEcCtD
Sulfamethoxazole—Pneumonia—Etoposide—muscle cancer	0.00207	0.00484	CcSEcCtD
Sulfamethoxazole—Aplastic anaemia—Methotrexate—muscle cancer	0.00207	0.00484	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Etoposide—muscle cancer	0.00206	0.00481	CcSEcCtD
Sulfamethoxazole—Infestation—Etoposide—muscle cancer	0.00206	0.00481	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Vincristine—muscle cancer	0.00206	0.0048	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00204	0.00477	CcSEcCtD
Sulfamethoxazole—Renal failure—Etoposide—muscle cancer	0.00203	0.00473	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Etoposide—muscle cancer	0.00202	0.00471	CcSEcCtD
Sulfamethoxazole—Stomatitis—Etoposide—muscle cancer	0.00201	0.00469	CcSEcCtD
Sulfamethoxazole—Mental disorder—Vincristine—muscle cancer	0.002	0.00467	CcSEcCtD
Sulfamethoxazole—Leukopenia—Dactinomycin—muscle cancer	0.00199	0.00465	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Etoposide—muscle cancer	0.00195	0.00455	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Etoposide—muscle cancer	0.00192	0.00449	CcSEcCtD
Sulfamethoxazole—Myalgia—Dactinomycin—muscle cancer	0.00189	0.00442	CcSEcCtD
Sulfamethoxazole—Hyperkalaemia—Doxorubicin—muscle cancer	0.00188	0.00438	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Etoposide—muscle cancer	0.00183	0.00426	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Methotrexate—muscle cancer	0.00182	0.00426	CcSEcCtD
Sulfamethoxazole—Polyuria—Methotrexate—muscle cancer	0.00182	0.00426	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Etoposide—muscle cancer	0.00181	0.00423	CcSEcCtD
Sulfamethoxazole—Aplastic anaemia—Doxorubicin—muscle cancer	0.00179	0.00419	CcSEcCtD
Sulfamethoxazole—Vertigo—Vincristine—muscle cancer	0.00179	0.00417	CcSEcCtD
Sulfamethoxazole—Leukopenia—Vincristine—muscle cancer	0.00178	0.00415	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Dactinomycin—muscle cancer	0.00178	0.00415	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Etoposide—muscle cancer	0.00175	0.00408	CcSEcCtD
Sulfamethoxazole—Anorexia—Dactinomycin—muscle cancer	0.00173	0.00404	CcSEcCtD
Sulfamethoxazole—Eye disorder—Etoposide—muscle cancer	0.00173	0.00403	CcSEcCtD
Sulfamethoxazole—Convulsion—Vincristine—muscle cancer	0.00172	0.00402	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Methotrexate—muscle cancer	0.0017	0.00396	CcSEcCtD
Sulfamethoxazole—Myalgia—Vincristine—muscle cancer	0.00169	0.00395	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Etoposide—muscle cancer	0.00167	0.0039	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Etoposide—muscle cancer	0.00167	0.00389	CcSEcCtD
Sulfamethoxazole—Chills—Etoposide—muscle cancer	0.00166	0.00387	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00165	0.00386	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Vincristine—muscle cancer	0.00162	0.00379	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Vincristine—muscle cancer	0.00159	0.00371	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Vincristine—muscle cancer	0.00159	0.00371	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Doxorubicin—muscle cancer	0.00158	0.00369	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Dactinomycin—muscle cancer	0.00158	0.00368	CcSEcCtD
Sulfamethoxazole—Fatigue—Dactinomycin—muscle cancer	0.00157	0.00365	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Doxorubicin—muscle cancer	0.00155	0.00362	CcSEcCtD
Sulfamethoxazole—Anorexia—Vincristine—muscle cancer	0.00155	0.00361	CcSEcCtD
Sulfamethoxazole—Ataxia—Methotrexate—muscle cancer	0.00151	0.00352	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00149	0.00347	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00148	0.00345	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00147	0.00343	CcSEcCtD
Sulfamethoxazole—Insomnia—Vincristine—muscle cancer	0.00147	0.00342	CcSEcCtD
Sulfamethoxazole—Renal impairment—Doxorubicin—muscle cancer	0.00146	0.0034	CcSEcCtD
Sulfamethoxazole—Vertigo—Etoposide—muscle cancer	0.00145	0.00338	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00144	0.00337	CcSEcCtD
Sulfamethoxazole—Leukopenia—Etoposide—muscle cancer	0.00144	0.00336	CcSEcCtD
Sulfamethoxazole—Purpura—Doxorubicin—muscle cancer	0.00144	0.00336	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Dactinomycin—muscle cancer	0.00144	0.00335	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Dactinomycin—muscle cancer	0.00144	0.00335	CcSEcCtD
Sulfamethoxazole—Hypoglycaemia—Doxorubicin—muscle cancer	0.00142	0.00332	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Vincristine—muscle cancer	0.00141	0.00329	CcSEcCtD
Sulfamethoxazole—Cough—Etoposide—muscle cancer	0.00141	0.00328	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Vincristine—muscle cancer	0.0014	0.00327	CcSEcCtD
Sulfamethoxazole—Fatigue—Vincristine—muscle cancer	0.0014	0.00326	CcSEcCtD
Sulfamethoxazole—Convulsion—Etoposide—muscle cancer	0.0014	0.00326	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Doxorubicin—muscle cancer	0.00139	0.00325	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Methotrexate—muscle cancer	0.00137	0.0032	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00136	0.00318	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Methotrexate—muscle cancer	0.00136	0.00317	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Dactinomycin—muscle cancer	0.00134	0.00312	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Vincristine—muscle cancer	0.00133	0.0031	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Methotrexate—muscle cancer	0.00131	0.00307	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Etoposide—muscle cancer	0.00131	0.00307	CcSEcCtD
Sulfamethoxazole—Ataxia—Doxorubicin—muscle cancer	0.0013	0.00304	CcSEcCtD
Sulfamethoxazole—Asthenia—Dactinomycin—muscle cancer	0.0013	0.00304	CcSEcCtD
Sulfamethoxazole—Neutropenia—Methotrexate—muscle cancer	0.00129	0.00302	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Etoposide—muscle cancer	0.00129	0.003	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Vincristine—muscle cancer	0.00128	0.00299	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Vincristine—muscle cancer	0.00128	0.00299	CcSEcCtD
Sulfamethoxazole—Skin disorder—Etoposide—muscle cancer	0.00128	0.00298	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Methotrexate—muscle cancer	0.00126	0.00295	CcSEcCtD
Sulfamethoxazole—Anorexia—Etoposide—muscle cancer	0.00125	0.00292	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00125	0.00291	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dactinomycin—muscle cancer	0.00124	0.0029	CcSEcCtD
Sulfamethoxazole—Pneumonia—Methotrexate—muscle cancer	0.00124	0.0029	CcSEcCtD
Sulfamethoxazole—Infestation—Methotrexate—muscle cancer	0.00123	0.00288	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Methotrexate—muscle cancer	0.00123	0.00288	CcSEcCtD
Sulfamethoxazole—Depression—Methotrexate—muscle cancer	0.00123	0.00287	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00122	0.00286	CcSEcCtD
Sulfamethoxazole—Renal failure—Methotrexate—muscle cancer	0.00121	0.00283	CcSEcCtD
Sulfamethoxazole—Stomatitis—Methotrexate—muscle cancer	0.0012	0.00281	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Vincristine—muscle cancer	0.0012	0.00279	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Doxorubicin—muscle cancer	0.00119	0.00277	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Doxorubicin—muscle cancer	0.00118	0.00274	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Etoposide—muscle cancer	0.00117	0.00273	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Methotrexate—muscle cancer	0.00117	0.00272	CcSEcCtD
Sulfamethoxazole—Asthenia—Vincristine—muscle cancer	0.00116	0.00272	CcSEcCtD
Sulfamethoxazole—Vomiting—Dactinomycin—muscle cancer	0.00115	0.00269	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Methotrexate—muscle cancer	0.00115	0.00269	CcSEcCtD
Sulfamethoxazole—Rash—Dactinomycin—muscle cancer	0.00115	0.00267	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Etoposide—muscle cancer	0.00114	0.00267	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Doxorubicin—muscle cancer	0.00114	0.00266	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Etoposide—muscle cancer	0.00113	0.00265	CcSEcCtD
Sulfamethoxazole—Fatigue—Etoposide—muscle cancer	0.00113	0.00264	CcSEcCtD
Sulfamethoxazole—Neutropenia—Doxorubicin—muscle cancer	0.00112	0.00262	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Vincristine—muscle cancer	0.00111	0.00259	CcSEcCtD
Sulfamethoxazole—Hepatitis—Methotrexate—muscle cancer	0.00111	0.00259	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Methotrexate—muscle cancer	0.00109	0.00255	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00109	0.00255	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Methotrexate—muscle cancer	0.00109	0.00254	CcSEcCtD
Sulfamethoxazole—Nausea—Dactinomycin—muscle cancer	0.00108	0.00252	CcSEcCtD
Sulfamethoxazole—Pneumonia—Doxorubicin—muscle cancer	0.00108	0.00251	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Etoposide—muscle cancer	0.00107	0.00251	CcSEcCtD
Sulfamethoxazole—Dizziness—Vincristine—muscle cancer	0.00107	0.0025	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Doxorubicin—muscle cancer	0.00107	0.00249	CcSEcCtD
Sulfamethoxazole—Infestation—Doxorubicin—muscle cancer	0.00107	0.00249	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00106	0.00247	CcSEcCtD
Sulfamethoxazole—Renal failure—Doxorubicin—muscle cancer	0.00105	0.00245	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Methotrexate—muscle cancer	0.00105	0.00245	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00105	0.00245	CcSEcCtD
Sulfamethoxazole—Urticaria—Etoposide—muscle cancer	0.00104	0.00244	CcSEcCtD
Sulfamethoxazole—Stomatitis—Doxorubicin—muscle cancer	0.00104	0.00243	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Etoposide—muscle cancer	0.00104	0.00242	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Etoposide—muscle cancer	0.00104	0.00242	CcSEcCtD
Sulfamethoxazole—Eye disorder—Methotrexate—muscle cancer	0.00104	0.00242	CcSEcCtD
Sulfamethoxazole—Tinnitus—Methotrexate—muscle cancer	0.00103	0.00241	CcSEcCtD
Sulfamethoxazole—Vomiting—Vincristine—muscle cancer	0.00103	0.00241	CcSEcCtD
Sulfamethoxazole—Rash—Vincristine—muscle cancer	0.00102	0.00239	CcSEcCtD
Sulfamethoxazole—Dermatitis—Vincristine—muscle cancer	0.00102	0.00239	CcSEcCtD
Sulfamethoxazole—Headache—Vincristine—muscle cancer	0.00102	0.00237	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00101	0.00236	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methotrexate—muscle cancer	0.001	0.00234	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methotrexate—muscle cancer	0.000999	0.00233	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Doxorubicin—muscle cancer	0.000998	0.00233	CcSEcCtD
Sulfamethoxazole—Chills—Methotrexate—muscle cancer	0.000994	0.00232	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methotrexate—muscle cancer	0.000971	0.00227	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Etoposide—muscle cancer	0.000968	0.00226	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methotrexate—muscle cancer	0.000965	0.00225	CcSEcCtD
Sulfamethoxazole—Nausea—Vincristine—muscle cancer	0.000964	0.00225	CcSEcCtD
Sulfamethoxazole—Hepatitis—Doxorubicin—muscle cancer	0.00096	0.00224	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Doxorubicin—muscle cancer	0.000948	0.00221	CcSEcCtD
Sulfamethoxazole—Asthenia—Etoposide—muscle cancer	0.000943	0.0022	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Doxorubicin—muscle cancer	0.000943	0.0022	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Doxorubicin—muscle cancer	0.000941	0.0022	CcSEcCtD
Sulfamethoxazole—Pruritus—Etoposide—muscle cancer	0.00093	0.00217	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Doxorubicin—muscle cancer	0.000907	0.00212	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Etoposide—muscle cancer	0.000899	0.0021	CcSEcCtD
Sulfamethoxazole—Eye disorder—Doxorubicin—muscle cancer	0.000897	0.00209	CcSEcCtD
Sulfamethoxazole—Tinnitus—Doxorubicin—muscle cancer	0.000895	0.00209	CcSEcCtD
Sulfamethoxazole—CYP2C8—renal system—muscle cancer	0.000875	0.0307	CbGeAlD
Sulfamethoxazole—Dizziness—Etoposide—muscle cancer	0.000869	0.00203	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Doxorubicin—muscle cancer	0.000867	0.00202	CcSEcCtD
Sulfamethoxazole—Vertigo—Methotrexate—muscle cancer	0.000867	0.00202	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Doxorubicin—muscle cancer	0.000865	0.00202	CcSEcCtD
Sulfamethoxazole—Leukopenia—Methotrexate—muscle cancer	0.000864	0.00202	CcSEcCtD
Sulfamethoxazole—Chills—Doxorubicin—muscle cancer	0.000861	0.00201	CcSEcCtD
Sulfamethoxazole—Cough—Methotrexate—muscle cancer	0.000842	0.00196	CcSEcCtD
Sulfamethoxazole—Mental disorder—Doxorubicin—muscle cancer	0.000841	0.00196	CcSEcCtD
Sulfamethoxazole—Convulsion—Methotrexate—muscle cancer	0.000836	0.00195	CcSEcCtD
Sulfamethoxazole—Vomiting—Etoposide—muscle cancer	0.000836	0.00195	CcSEcCtD
Sulfamethoxazole—Malnutrition—Doxorubicin—muscle cancer	0.000835	0.00195	CcSEcCtD
Sulfamethoxazole—Rash—Etoposide—muscle cancer	0.000829	0.00193	CcSEcCtD
Sulfamethoxazole—Dermatitis—Etoposide—muscle cancer	0.000828	0.00193	CcSEcCtD
Sulfamethoxazole—Headache—Etoposide—muscle cancer	0.000823	0.00192	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methotrexate—muscle cancer	0.000821	0.00192	CcSEcCtD
Sulfamethoxazole—Myalgia—Methotrexate—muscle cancer	0.000821	0.00192	CcSEcCtD
Sulfamethoxazole—Tension—Doxorubicin—muscle cancer	0.00082	0.00191	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000816	0.0019	CcSEcCtD
Sulfamethoxazole—Nervousness—Doxorubicin—muscle cancer	0.000811	0.00189	CcSEcCtD
Sulfamethoxazole—ALB—testis—muscle cancer	0.000804	0.0283	CbGeAlD
Sulfamethoxazole—Anaphylactic shock—Methotrexate—muscle cancer	0.000787	0.00184	CcSEcCtD
Sulfamethoxazole—Nausea—Etoposide—muscle cancer	0.000781	0.00182	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methotrexate—muscle cancer	0.000772	0.0018	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Methotrexate—muscle cancer	0.000771	0.0018	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methotrexate—muscle cancer	0.000765	0.00178	CcSEcCtD
Sulfamethoxazole—Vertigo—Doxorubicin—muscle cancer	0.00075	0.00175	CcSEcCtD
Sulfamethoxazole—Anorexia—Methotrexate—muscle cancer	0.00075	0.00175	CcSEcCtD
Sulfamethoxazole—Leukopenia—Doxorubicin—muscle cancer	0.000748	0.00174	CcSEcCtD
Sulfamethoxazole—PTGS1—smooth muscle tissue—muscle cancer	0.000737	0.0259	CbGeAlD
Sulfamethoxazole—Cough—Doxorubicin—muscle cancer	0.000729	0.0017	CcSEcCtD
Sulfamethoxazole—Convulsion—Doxorubicin—muscle cancer	0.000724	0.00169	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000717	0.00167	CcSEcCtD
Sulfamethoxazole—Insomnia—Methotrexate—muscle cancer	0.000712	0.00166	CcSEcCtD
Sulfamethoxazole—Arthralgia—Doxorubicin—muscle cancer	0.000711	0.00166	CcSEcCtD
Sulfamethoxazole—Myalgia—Doxorubicin—muscle cancer	0.000711	0.00166	CcSEcCtD
Sulfamethoxazole—PTGS1—renal system—muscle cancer	0.000709	0.0249	CbGeAlD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000706	0.00165	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Methotrexate—muscle cancer	0.000702	0.00164	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methotrexate—muscle cancer	0.000693	0.00162	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Methotrexate—muscle cancer	0.000684	0.0016	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Doxorubicin—muscle cancer	0.000682	0.00159	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00068	0.00159	CcSEcCtD
Sulfamethoxazole—Fatigue—Methotrexate—muscle cancer	0.000679	0.00158	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Doxorubicin—muscle cancer	0.000669	0.00156	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Doxorubicin—muscle cancer	0.000667	0.00156	CcSEcCtD
Sulfamethoxazole—Skin disorder—Doxorubicin—muscle cancer	0.000662	0.00155	CcSEcCtD
Sulfamethoxazole—Anorexia—Doxorubicin—muscle cancer	0.00065	0.00152	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methotrexate—muscle cancer	0.000644	0.0015	CcSEcCtD
Sulfamethoxazole—PTGS1—cardiac atrium—muscle cancer	0.000635	0.0223	CbGeAlD
Sulfamethoxazole—CYP2C8—vagina—muscle cancer	0.000634	0.0223	CbGeAlD
Sulfamethoxazole—Urticaria—Methotrexate—muscle cancer	0.000625	0.00146	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methotrexate—muscle cancer	0.000622	0.00145	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Methotrexate—muscle cancer	0.000622	0.00145	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000621	0.00145	CcSEcCtD
Sulfamethoxazole—Insomnia—Doxorubicin—muscle cancer	0.000617	0.00144	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Doxorubicin—muscle cancer	0.000608	0.00142	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Doxorubicin—muscle cancer	0.0006	0.0014	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Doxorubicin—muscle cancer	0.000593	0.00138	CcSEcCtD
Sulfamethoxazole—CYP3A4—renal system—muscle cancer	0.000592	0.0208	CbGeAlD
Sulfamethoxazole—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000589	0.00137	CcSEcCtD
Sulfamethoxazole—Fatigue—Doxorubicin—muscle cancer	0.000588	0.00137	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methotrexate—muscle cancer	0.00058	0.00135	CcSEcCtD
Sulfamethoxazole—CYP2C8—testis—muscle cancer	0.000565	0.0199	CbGeAlD
Sulfamethoxazole—Asthenia—Methotrexate—muscle cancer	0.000565	0.00132	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000557	0.0013	CcSEcCtD
Sulfamethoxazole—Pruritus—Methotrexate—muscle cancer	0.000557	0.0013	CcSEcCtD
Sulfamethoxazole—PTGS1—tendon—muscle cancer	0.000554	0.0195	CbGeAlD
Sulfamethoxazole—Urticaria—Doxorubicin—muscle cancer	0.000542	0.00126	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Doxorubicin—muscle cancer	0.000539	0.00126	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Doxorubicin—muscle cancer	0.000539	0.00126	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methotrexate—muscle cancer	0.000539	0.00126	CcSEcCtD
Sulfamethoxazole—Dizziness—Methotrexate—muscle cancer	0.000521	0.00122	CcSEcCtD
Sulfamethoxazole—PTGS1—vagina—muscle cancer	0.000514	0.0181	CbGeAlD
Sulfamethoxazole—Hypersensitivity—Doxorubicin—muscle cancer	0.000502	0.00117	CcSEcCtD
Sulfamethoxazole—Vomiting—Methotrexate—muscle cancer	0.000501	0.00117	CcSEcCtD
Sulfamethoxazole—Rash—Methotrexate—muscle cancer	0.000496	0.00116	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methotrexate—muscle cancer	0.000496	0.00116	CcSEcCtD
Sulfamethoxazole—Headache—Methotrexate—muscle cancer	0.000493	0.00115	CcSEcCtD
Sulfamethoxazole—Asthenia—Doxorubicin—muscle cancer	0.000489	0.00114	CcSEcCtD
Sulfamethoxazole—Pruritus—Doxorubicin—muscle cancer	0.000482	0.00113	CcSEcCtD
Sulfamethoxazole—PTGS1—head—muscle cancer	0.000475	0.0167	CbGeAlD
Sulfamethoxazole—Nausea—Methotrexate—muscle cancer	0.000468	0.00109	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Doxorubicin—muscle cancer	0.000466	0.00109	CcSEcCtD
Sulfamethoxazole—PTGS1—testis—muscle cancer	0.000458	0.0161	CbGeAlD
Sulfamethoxazole—Dizziness—Doxorubicin—muscle cancer	0.000451	0.00105	CcSEcCtD
Sulfamethoxazole—Vomiting—Doxorubicin—muscle cancer	0.000433	0.00101	CcSEcCtD
Sulfamethoxazole—Rash—Doxorubicin—muscle cancer	0.00043	0.001	CcSEcCtD
Sulfamethoxazole—Dermatitis—Doxorubicin—muscle cancer	0.000429	0.001	CcSEcCtD
Sulfamethoxazole—Headache—Doxorubicin—muscle cancer	0.000427	0.000997	CcSEcCtD
Sulfamethoxazole—Nausea—Doxorubicin—muscle cancer	0.000405	0.000945	CcSEcCtD
